Distinguishing Bronchial Carcinoid from Benign Bronchocele using <sup>68</sup>Ga-DOTATOC PET/CT Imaging
PDF
Cite
Share
Request
Interesting Image
P: -

Distinguishing Bronchial Carcinoid from Benign Bronchocele using 68Ga-DOTATOC PET/CT Imaging

Mol Imaging Radionucl Ther 0;0(0):undefined-undefined
1. King Hussein Cancer Center (KHCC) Department of Nuclear Medicine and PET/CT, Amman, Jordan
2. University of Jordan Department of Radiology and Nuclear Medicine, Division of Nuclear Medicine, Amman, Jordan
3. King Hussein Cancer Center (KHCC) Department of Pathology, Amman, Jordan
No information available.
No information available
PDF
Cite
Share
Request

Abstract

Bronchial carcinoids are low-grade neuroendocrine tumors with slow growth rates and the potential to spread to nearby lymph nodes. Here we present a challenging case of bronchial carcinoid visualized alongside an adjacent benign bronchocele. Chest computed tomography (CT) identified the endobronchial mass with unclear morphological and diagnostic insights. A differential diagnosis of several benign and malignant etiologies was made. Subsequently, an endobronchial biopsy confirmed lung carcinoid. For better evaluation, a 68Ga-labeled 1,4,7,10-tetraazacyclododecane-N,N’,N’’,N’’’-tetraacetic acid-d-Phe1-Tyr3-octreotide (68Ga-DOTATOC) positron emission tomography/CT (PET/CT) scan was performed. The scan revealed a locally confined endobronchial mass with intense 68Ga-DOTATOC expression. Adjacent benign bronchocele was visualized with insignificant 68Ga-DOTATOC expression. Histopathological examination of the resected upper lobe confirmed these findings. This case highlights the importance of somatostatin receptor imaging in accurately identifying the extent of carcinoid tumors in the primary, nodal, and metastatic domains.

Keywords: Bronchocele, bronchial carcinoid, diagnostic challenge, 68Ga-DOTATOC, somatostatin receptor imaging, PET/CT

References

2024 ©️ Galenos Publishing House